Nicolas H.R. Dumont


I am passionate about helping clients execute strategic transactions in the capital markets and guiding them through an increasingly complex regulatory environment.

Nicolas advises corporate and investment banking clients in public and private corporate finance transactions. His experience encompasses initial public offerings, special purpose acquisition companies (SPACs), common and preferred stock issuances, at-the-market offerings, private placements and rights offerings, and senior, subordinated and convertible debt offerings (including non-dollar-denominated debt), as well as securities issued by banks, hybrid and derivative instruments, private investment in public equity (PIPE) offerings, tender offers, consent solicitations, and exchange offers.

Download full bio 


  • Silence Therapeutics – $56.5 Million Registered Direct Offering 

  • Alvotech Agrees to Merge With SPAC Oaktree Acquisition Corp. II 

  • Packable Agrees to SPAC Merger With Highland Transcend Partners | Corp. 

  • Core Scientific to Combine With SPAC Power & Digital Infrastructure Acquisition Corp. 

  • CS Disco – $246 Million IPO 

  • View all


  • Stanford Law School

  • Princeton University
    AB, summa cum laude

  • Institut d'Etudes Politiques de Paris
    Diplôme, Sciences-Po

Admissions & Credentials

New York